These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

784 related articles for article (PubMed ID: 26912547)

  • 1. Masked Hypertension and Elevated Nighttime Blood Pressure in CKD: Prevalence and Association with Target Organ Damage.
    Drawz PE; Alper AB; Anderson AH; Brecklin CS; Charleston J; Chen J; Deo R; Fischer MJ; He J; Hsu CY; Huan Y; Keane MG; Kusek JW; Makos GK; Miller ER; Soliman EZ; Steigerwalt SP; Taliercio JJ; Townsend RR; Weir MR; Wright JT; Xie D; Rahman M;
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):642-52. PubMed ID: 26912547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood Pressure Pattern and Target Organ Damage in Patients With Chronic Kidney Disease.
    Scheppach JB; Raff U; Toncar S; Ritter C; Klink T; Störk S; Wanner C; Schlieper G; Saritas T; Reinartz SD; Floege J; Janka R; Uder M; Schmieder RE; Eckardt KU; Schneider MP
    Hypertension; 2018 Oct; 72(4):929-936. PubMed ID: 30354716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Masked Hypertension in CKD: Increased Prevalence and Risk for Cardiovascular and Renal Events.
    Babu M; Drawz P
    Curr Cardiol Rep; 2019 May; 21(7):58. PubMed ID: 31111326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Significance of Ambulatory BP Monitoring in CKD: A Report from the Chronic Renal Insufficiency Cohort (CRIC) Study.
    Rahman M; Wang X; Bundy JD; Charleston J; Cohen D; Cohen J; Drawz PE; Ghazi L; Horowitz E; Lash JP; Schrauben S; Weir MR; Xie D; Townsend RR;
    J Am Soc Nephrol; 2020 Nov; 31(11):2609-2621. PubMed ID: 32973085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between office and 24-hour blood pressure control in hypertensive patients with CKD: A 5,693-patient cross-sectional analysis from Spain.
    Gorostidi M; Sarafidis PA; de la Sierra A; Segura J; de la Cruz JJ; Banegas JR; Ruilope LM;
    Am J Kidney Dis; 2013 Aug; 62(2):285-94. PubMed ID: 23689071
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood Pressure Control in Hypertensive Patients, Cardiovascular Risk Profile and the Prevalence of Masked Uncontrolled Hypertension (MUCH).
    Naser N; Dzubur A; Durak A; Kulic M; Naser N
    Med Arch; 2016 Jul; 70(4):274-279. PubMed ID: 27703288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disparate estimates of hypertension control from ambulatory and clinic blood pressure measurements in hypertensive kidney disease.
    Pogue V; Rahman M; Lipkowitz M; Toto R; Miller E; Faulkner M; Rostand S; Hiremath L; Sika M; Kendrick C; Hu B; Greene T; Appel L; Phillips RA;
    Hypertension; 2009 Jan; 53(1):20-7. PubMed ID: 19047584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variations in 24-Hour BP Profiles in Cohorts of Patients with Kidney Disease around the World: The I-DARE Study.
    Drawz PE; Brown R; De Nicola L; Fujii N; Gabbai FB; Gassman J; He J; Iimuro S; Lash J; Minutolo R; Phillips RA; Rudser K; Ruilope L; Steigerwalt S; Townsend RR; Xie D; Rahman M;
    Clin J Am Soc Nephrol; 2018 Sep; 13(9):1348-1357. PubMed ID: 29976600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Masked hypertension, rather than white-coat hypertension, has a prognostic role in patients with non-dialysis chronic kidney disease.
    Wang C; Zhang J; Li Y; Ma X; Ye Z; Peng H; Lou T
    Int J Cardiol; 2017 Mar; 230():33-39. PubMed ID: 28034462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence, determinants, and clinical significance of masked hypertension and white-coat hypertension in patients with chronic kidney disease.
    Tang H; Gong WY; Zhang QZ; Zhang J; Ye ZC; Peng H; Wang C; Lou T
    Nephrology (Carlton); 2016 Oct; 21(10):841-50. PubMed ID: 26566951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nighttime Systolic Blood-Pressure Load Is Correlated with Target-Organ Damage Independent of Ambulatory Blood-Pressure Level in Patients with Non-Diabetic Chronic Kidney Disease.
    Wang C; Zhang J; Deng W; Gong W; Liu X; Ye Z; Peng H; Lou T
    PLoS One; 2015; 10(7):e0131546. PubMed ID: 26186336
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Target Organ Complications and Cardiovascular Events Associated With Masked Hypertension and White-Coat Hypertension: Analysis From the Dallas Heart Study.
    Tientcheu D; Ayers C; Das SR; McGuire DK; de Lemos JA; Khera A; Kaplan N; Victor R; Vongpatanasin W
    J Am Coll Cardiol; 2015 Nov; 66(20):2159-2169. PubMed ID: 26564592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory Blood Pressure Phenotypes in Adults Taking Antihypertensive Medication with and without CKD.
    Mwasongwe SE; Tanner RM; Poudel B; Pugliese DN; Young BA; Abdalla M; Musani SK; Gutiérrez OM; Correa A; Shimbo D; Muntner P
    Clin J Am Soc Nephrol; 2020 Apr; 15(4):501-510. PubMed ID: 32217635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease.
    Mojón A; Ayala DE; Piñeiro L; Otero A; Crespo JJ; Moyá A; Bóveda J; de Lis JP; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):145-58. PubMed ID: 23181690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes of blood pressure patterns and target organ damage in patients with chronic kidney disease: results of the APrODiTe-2 study.
    Cha RH; Lee H; Lee JP; Kang E; Song YR; Kim YS; Kim SG
    J Hypertens; 2017 Mar; 35(3):593-601. PubMed ID: 27926690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dipping Status, Ambulatory Blood Pressure Control, Cardiovascular Disease, and Kidney Disease Progression: A Multicenter Cohort Study of CKD.
    Borrelli S; Garofalo C; Gabbai FB; Chiodini P; Signoriello S; Paoletti E; Ravera M; Bussalino E; Bellizzi V; Liberti ME; De Nicola L; Minutolo R
    Am J Kidney Dis; 2023 Jan; 81(1):15-24.e1. PubMed ID: 35709922
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Masked Uncontrolled Hypertension in CKD.
    Agarwal R; Pappas MK; Sinha AD
    J Am Soc Nephrol; 2016 Mar; 27(3):924-32. PubMed ID: 26163421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of Cardiovascular Outcomes With Masked Hypertension Defined by Home Blood Pressure Monitoring in a Japanese General Practice Population.
    Fujiwara T; Yano Y; Hoshide S; Kanegae H; Kario K
    JAMA Cardiol; 2018 Jul; 3(7):583-590. PubMed ID: 29800067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Home blood pressure measurement as a systematic tool for clinical practice in CKD patients: a real-world picture.
    Cupisti A; Ghiadoni L; Zullo C; Marchini M; Varricchio E; Puntoni A; Giglio E; Meniconi O; Bruno MR; Egidi MF
    Panminerva Med; 2018 Mar; 60(1):1-7. PubMed ID: 29164841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.